Fig 1.
Study flow chart.
Table 1.
Baseline characteristics.
Fig 2.
(A) Total episodes of frequent atrial tachyarrhythmias: a composite of definite recurrent atrial tachyarrhythmias, frequent premature atrial contractions (PACs), and PAC short runs during the treatment period of 30-day. (B) Cumulative incidence of the first episode of clinical outcomes.
Fig 3.
Timing of frequent atrial tachyarrhythmias during the treatment period of 30 days.
Fig 4.
Serum biomarkers and quality of life after the procedure.
A) Cardiac enzymes, B) Inflammatory biomarkers, C) Natriuretic peptides, D) QOL score, and E) clinical outcomes during the index admission. BNP = brain natriuretic peptides; CK = creatine kinase; CRP = C-reacting protein; IV = intravenous; NT-proBNP = N-terminal pro-brain natriuretic peptides; QOL = quality of life; TnI = troponin I; WBC = white blood cell.
Table 2.
Adverse clinical symptoms over 30 days.